GUIA I RECOMANACIONS PER A LA REALITZACIÓ I PRESENTACIÓ D'AVALUACIONS ECONÒMIQUES I ANÀLISIS D'IMPACTE PRESSUPOSTARI DE MEDICAMENTS EN L’ÀMBIT DEL CATSALUT
As resources are scarce we do have to prioritise. That's it, we can't escape. We do need a proxy to assess relative incremental value of the technologies and procedures for a disease, otherwise decisions would be arbitrary. In such situation a methodologic guide is welcome to provide credible information. This is precisely what the guide by CatSalut is contributing to. It explains criteria and ways to present economic evaluation and budget impact analysis. A well designed guide that unfortunately right now will have a limited application. The reason is that government can't completely decide about it. It's an issue of months.
